Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03445572 · ClinicalTrials.gov registry record · NA

Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With Cancer

A NA study of Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
41
Enrollment target
1
Study location

NCT03445572 is a NA study of Malignant Neoplasm that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 41 participants, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03445572, a NA study of Malignant Neoplasm, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well meditative slow breathing or Isha Kriya meditation works in improving cancer-related symptoms in hospitalized participants with cancer. Meditative slow breathing or Isha Kriya meditation may help to decrease perceived stress and enhance well-being in hospitalized cancer participants.

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • PROCEDURE Meditation Therapy

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2018-09-21
Est. Completion 2020-08-04
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT03445572

The ClinicalTrials.gov registry entry for NCT03445572 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (92% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Malignant Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT03445572 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03445572 about?

NCT03445572 is a clinical study titled "Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With Cancer". This trial studies how well meditative slow breathing or Isha Kriya meditation works in improving cancer-related symptoms in hospitalized participants with cancer. Meditative slow breathing or Isha Kriya meditation may help to decrease perceived stress and enhance well-being in hospitalized cancer p...

What is the current status of trial NCT03445572?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2018-09-21. Estimated completion is 2020-08-04.

What conditions does trial NCT03445572 study?

This clinical trial studies the following conditions: Malignant Neoplasm.

What interventions are being tested in trial NCT03445572?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Meditation Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT03445572?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03445572 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.